PDCD1 and Sepsis: For example, monoclonal antibodies against PD-1 and PD-L1 for the treatment of sepsis are under investigation, as are TLR agonists combined with PD-1 inhibitors against solid tumors, based on the hypothesis that combined treatment could enhance the effectiveness of PD-1 blockade [47,48].